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ABSTRACT: There is controversy regarding whether obstructive sleep apnea is responsible for triggering myocardial ischemia, 
arrhythmias and heart rate variability in patients with coronary artery disease. 
OBJETIVE: The objective of this study was to identify relationships between sleep apnea, myocardial ischemia and cardiac ar-
rhythmia in patients with coronary artery disease. 
METHODS: Fifty-three patients with stable coronary disease underwent simultaneous polysomnography and electrocardiographic 
Holter recording. The apnea-hypopnea index (AHI) was defined as the number of apneas/hypopneas per hour of sleep. Patients 
were divided into a Control group (AHI15, n=23 pts) and an Apnea group (AHI>15, n=30 pts). A subgroup of 13 patients with an 
AHI>30 (Severe Apnea group) was also studied. We analyzed ischemic episodes (ST-segment depressions >1 mm, ≥ 1 min), heart 
rate variability and the occurrence of arrhythmias during wakefulness and sleep. 
RESULTS: Baseline clinical characteristics among the groups were similar except for higher blood pressure in the Apnea groups 
(p<0.05). Myocardial ischemia was recorded in 39 (73.6%) patients. The number and duration of ischemic episodes significantly 
decreased during sleep in all groups; during wakefulness, patients with severe apnea exhibited fewer and shorter episodes in com-
parison with the controls. There were no significant differences in heart rate variability or in the occurrence of arrhythmias among 
the groups. Malignant ventricular arrhythmias, atrial fibrillation/flutter, bradycardia and high-degree atrioventricular blocks were 
not detected. 
CONCLUSION: Obstructive sleep apnea was not related to myocardial ischemia, heart rate variability or arrhythmias in patients 
with stable coronary artery disease and did not alter the circadian pattern of myocardial ischemia.
KEYWORDS: Sleep apnea; Myocardial ischemia; Heart rate variability; Arrhythmias.
INTRODUCTION
Sleep apnea is reported in about 2% of middle-aged 
women and 4% of middle-aged men, but prevalence rates of 
up to 24% of the adult population have been observed.1 Most 
of the patients are elderly, male and obese with increased 
neck circumference and craniofacial abnormalities. A 
higher prevalence is also observed in diabetics, and among 
those who drink, or who use sedatives and hypnotics. 
Sleep apnea can be classified as obstructive, central or 
mixed. The obstructive type (OSA) is the most frequent 
and is associated with high morbidity; it is characterized by 
recurrent episodes of partial or complete obstruction of the 
upper airways during sleep, with a consequent decrease in 
oxygen saturation.2,3 The severity of apnea is defined by the 
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apnea-hypopnea index (AHI) as mild (AHI between 5 and 
15), moderate (AHI between 16 and 30) and severe (AHI > 
30), with hemodynamic changes in individuals with an AHI 
>15.2 An increased incidence of OSA has been reported 
among patients with cardiovascular diseases,4,5 and there 
is evidence that cardiovascular risk may decrease in these 
patients when OSA is treated efficiently.6 
Frequent episodes of hypoxemia in the context of apnea 
have been associated with increased sympathetic activity,7 
endothelial dysfunction8 and systemic inflammation,9 all of 
which are implicated in the process of atherogenesis. Some 
authors consider sleep apnea to be an acute risk factor for the 
rupture of vulnerable plaques, resulting in acute myocardial 
infarction.9 The increased incidence of myocardial ischemia 
has been reported among patients with coronary heart disease 
and OSA,4,6 and changes in the ST-segment have also been 
observed during sleep in OSA patients and in those without 
coronary obstructions.10 Moreover, increased sympathetic 
activity may trigger malignant ventricular arrhythmias and 
sudden death.11 Nocturnal ventricular arrhythmias were 
observed in patients with severe apnea,12 but others have 
reported only isolated ventricular ectopic beats.13 
These observations cumulatively suggest an association 
between OSA and cardiovascular disease; however, the 
relationship between sleep apnea and ischemic events 
remains controversial. 
The present study was designed to assess the possible 
influence of the degree of OSA on myocardial ischemia, 
heart rate variability and arrhythmias in patients with 
stable coronary heart disease. Our goal was to elucidate the 
relationship between sleep apnea and ischemic events.
MATERIALS AND METHODS
This study involved outpatients with stable ischemic 
heart disease at a Tertiary Cardiovascular Care Center at 
Hospital das Clínicas, Faculdade de Medicina, Univerisdade 
de São Paulo. Patients were recruited to participate in the 
study from July 2002 to June 2005 and all gave their written 
informed consent. The study was approved by the Hospital 
Ethical Committee. Individuals initially completed the Berlin 
Questionnaire14 in order to assess the clinical probability 
of having OSA. We only included patients at high risk 
for sleep apnea. Exclusion criteria included persistent 
electrocardiographic changes that would compromise the 
diagnosis of ischemia (bundle-branch block, high-degree 
atrioventricular block, atrial fibrillation or marked left 
ventricular hypertrophy), congestive heart failure, severe 
ventricular dysfunction, recent (less than 6 months prior) 
acute myocardial infarction, unstable angina, myocardial 
revascularization, stroke, artificial cardiac pacemaker and 
dependence on medications such as digoxin, diuretics, 
coronary vasodilators, beta-blockers or anti-arrhythmic 
drugs. 
We enrolled a total of 53 patients with documented 
ischemic heart disease, 40 (75.5%) of whom were men with 
ages ranging from 31 to 80 yrs (mean 58.8 yrs). Forty-one 
(77.4%) patients were submitted to coronary arteriography 
1-3 months before recruitment. Twenty-seven (50.94%) 
patients had angina or previous myocardial infarction and 
the remaining patients exhibited positive exercise stress test 
results or myocardial perfusion scintigraphy. A significant 
coronary lesion was defined by a 70% or greater reduction 
in luminal diameter in a major coronary artery or in a major 
branch. A 50% or greater stenosis in the left main coronary 
artery was also considered significant.15 The left ventricular 
ejection fraction was calculated using the modified Dodge 
area-length method.16,17 Thirty-two (78%) patients had 
multivessel disease, and all patients had an ejection fraction 
>40%.
Study protocol: All 53 patients were submitted to 
simultaneous 24-hour ambulatory electrocardiographic 
monitoring (Holter system) and polysomnography in order 
to analyze myocardial ischemia, heart rate variability and 
arrhythmias during wakefulness and sleep. Drugs that could 
interfere with ECG analysis (e.g., beta blockers, calcium 
antagonists, long-acting nitrates and digitalis) were withheld 
for 3 to 7 days before initiation of the protocol. During this 
period, patients were instructed to take sublingual nitrates as 
needed for symptoms and to contact the main investigator 
immediately if disabling symptoms occurred.
Polysomnography was performed in the Sleep Laboratory 
using an Embla system with digital recording capability 
(Embla, Flagra hf Medical Devices, Reykjavik, Iceland). 
Physiological sensor leads were placed on the patients in 
order to record brain electrical activity, eye and jaw muscle 
movement, leg muscle movement, airflow, respiratory 
effort (chest and abdominal excursions), electrocardiogram 
and oxygen saturation. Apnea was defined as a complete 
cessation of airflow for at least 10 seconds, and hypopnea 
was defined as a reduction in respiratory signals for at least 
10 seconds associated with an oxygen desaturation of 3%.3,18 
The apnea-hypopnea index (AHI) was calculated in terms of 
the number of apneas/hypopneas per hour of sleep (3). OSA 
was diagnosed in subjects with an AHI ≥ 5.2,19 
Patients were divided into two groups according to their 
AHI, a Control group (AHI ≤15) consisting of 23 patients 
and an Apnea group (AHI>15) consisting of 30 patients. 
In the Apnea group, a subgroup of 13 patients with severe 
apnea (AHI>30) was analyzed separately (Severe Apnea 
group) and compared to the Control group. 
Ambulatory electrocardiograph monitoring using the 
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Holter system was conducted for 24 consecutive hours 
and obtained by a portable two-channel analog recorder 
(Marquette series 8500) with a fixed calibration of 1 mV = 
10 mm and wave recording in modulated amplitude (MA) 
mode. Two bipolar leads, the CM5 (exploring electrode in 
the V5 position) and the CM1 or modified D2 (exploring 
electrode in an inferior lead), were used. To acquire the 
neutral value, an electrode was placed close to the final 
costal arches, next to the midclavicular line. Baseline 
electrocardiograms were recorded in all patients. After the 
monitor was withdrawn, the tapes were analyzed using 
the MARS system (Marquette). Maximum, minimum and 
mean heart rates were determined and the occurrence of 
ST-segment deviations and arrhythmias were recorded. 
An ischemic episode was defined as either a transient 
ST-segment elevation or a horizontal or downsloping ST-
segment depression of 1mm or more from the baseline, 
measured 60 to 80 ms after the J point and lasting 1 minute 
or longer.15,20 The heart rate variability was determined by 
time- and frequency-domain analysis20,21 and quantified 
every 5 minutes over a total period of 30 minutes. For each 
patient, two values of heart rate variability were obtained 
immediately before deploying the polysomnography 
hardware (pre-polysomnography period) and immediately 
after removing it (post-polysomnography period). The 
time-domain parameters included standard deviations of all 
R-R intervals, the percentage of differences between R-R 
intervals that differed more than 50 ms and the root mean 
square of the difference between two adjacent R-R intervals 
(SDNN, pNN50 and RMSSD, respectively). The frequency-
domain components included the low-frequency (LF) 
component (between 0.04-0.15 Hz) and the high frequency 
(HF) component (between 0.15-0.40 Hz). From these values, 
the ratio of LF/HF was also determined. Arrhythmias were 
analyzed manually if diagnosed, and sinus pauses >3 seconds 
were considered significant. 
Patients received a questionnaire and were instructed 
to report their activities and the occurrence of any adverse 
symptoms. 
Statistical analysis: Results are expressed as mean 
± SD. The chi-square test or Fisher’s exact test (for any 
expected frequencies of less than five) were used for the 
analysis of categorical variables. A Student’s t-test was used 
for continuous variables. A non-parametric Mann-Whitney 
test was used when groups were assumed to have an unequal 
distribution. To compare wakefulness and sleep, a non-
parametric Wilcoxon test was used because the assumed 
normality of the data was rejected. The statistical software 
used was SAS 9.1. The significance level used for the tests 
was set to 5%.
RESULTS
Baseline clinical characteristics are listed in table 1. No 
significant differences were observed among the groups 
except for the higher blood pressure levels in the Severe 
Apnea group and the higher diastolic blood pressure in the 
Apnea group when compared to the Control group. The 
Table 1 - Baseline clinical characteristics
Control (AHI≤15; n=23) Apnea (AHI>15; n=30) Severe Apnea (AHI>30; n=13)
Age (years) 57.47 ± 10.59 59.00 ± 10.42 58.38 ± 10.17
Females (%) 34.78 16.67 30.77
BMI (kg/m2) 27.94 ± 3.95 29.90 ± 7.85 32.76 ± 10.73
SBP (mmHg) 136.08 ± 16.71 146.33 ± 23.03 158.46 ± 23.75**
DBP (mmHg) 81.30 ± 12.17 91.33 ± 16.96* 96.15 ± 19.80**
Symptoms (%) 52.17 50.00 53.85
Hypertension (%) 65.22 83.33 92.31
Diabetes (%) 13.04 36.67 23.08
Dyslipidemia (%) 39.13 40.00 38.46
Smokers (%) 21.74 10.00 15.38
Snoring (%) 85.71 88.46 100
Neck (cm) 37.13 ± 8.10 39.63 ± 3.51 40.57 ± 4.07
SpO2 – awake (%) 94.03 ± 1.70 93.32 ± 1.72 93.08 ± 2.02
SpO2max – sleep (%) 93.30 ± 1.98 92.27 ± 2.43 91.56 ± 3.04
SpO2min – sleep (%) 85.65 ± 2.99 76.20 ± 9.40* 76.30 ± 7.66**
*Apnea vs. Control p<0.05; ** Severe Apnea vs. Control p<0.05 
BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; SpO2: oxygen saturation
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oxygen saturation levels did not differ when the subjects 
were awake. There was, however, a significant decrease in 
minimum oxygen saturation during sleep in the Apnea and 
Severe Apnea groups when compared to the Control group. 
The groups did not differ in the extent of coronary disease 
or ventricular impairment. Multivessel coronary disease was 
detected in 76.5%, 79.2% and 81.8% of the Control, Apnea 
and Severe Apnea patients, respectively.
All patients remained clinically stable during the study 
and no patient awoke due to nocturnal angina. 
 Ischemic episodes were quantified in terms of number 
and duration. Myocardial ischemia was recorded in 39 
(73.6%) patients, 19 of whom (35.8%) also presented with 
ischemia during sleep. The number and duration of ischemic 
episodes per hour decreased significantly in all groups during 
sleep as compared to wakefulness (Figure 1). 
There was no significant difference in the number or 
duration of ischemic episodes during sleep among the 
groups (Figure 2). During wakefulness, however, there were 
significantly fewer and shorter ischemic episodes in the 
Severe Apnea group as compared to the Control group. 
Heart rate variability was not significantly different 
between the three groups during the pre- and post-
polysomnography periods (Table 2). When comparing the 
post-polysomnography period to the pre-polysomnography 
period in the Control group, we found a decrease in the 
time domain parameters. This difference, however, was 
only significant for SDNN values (p=0.014). An increase 
in the LF component and a decrease in the HF component 
were also observed, but the differences were not significant. 
In the Apnea and Severe Apnea groups, a non-uniform 
decrease in SDNN and an increase in RMSSD and PNN50 
were observed, but only the decreases in SDNN values in the 
Figure 1 - Comparison of the number and duration of ischemic episodes per 
hour during wakefulness and sleep in the same group
Figure 2 - Comparison of the number and duration of ischemic episodes 
in the different groups
Table 2 - Heart rate variability in the three groups during pre- and post-
polysomnography periods
HRV Pre-P 
Mean ± SD
Post-P 
Mean ± SD
Control 
(n=23)
SDNN (ms) 78.5 6 ± 26.57 64.39 ± 21.40
RMSSD (ms) 35.00 ± 28.75 29.27 ± 15.26
PNN50 (ms) 12.04 ± 16.76 8.78 ± 11.43
LF (ms) 702.21 ± 410.78 791.17 ± 525.98
HF (ms) 312.43 ± 402.05 247.56 ± 300.49
LF/HF 4.08 ± 3.77 6.26 ± 8.98
Apnea 
(n=30)
SDNN (ms) 73.06 ± 31.83 61.56 ± 25.69
RMSSD (ms) 28.20 ± 10.90 29.83 ± 21.30
PNN50 (ms) 7.86 ± 7.59 9.30 ± 15.40
LF (ms) 717.76 ± 563.65 661.20 ± 720.62
HF (ms) 182.50 ± 146.00 222.76 ± 373.14
LF/HF 4.20 ± 3.05 5.13 ± 3.83
Severe Apnea 
(n=13)
SDNN (ms) 68.46 ± 25.19 55.84 ± 24.95
RMSSD (ms) 28.53 ± 10.05 32.07 ± 26.06
PNN50 (ms) 8.00 ± 6.28 10.15 ± 18.08
LF (ms) 632.23 ± 513.72 534.84 ± 493.63
HF (ms) 209.00 ± 183.06 260.92 ± 492.62
LF/HF 3.38 ± 2.53 5.07 ± 3.68
Pre-P: pre-polysomnography; Post-P: post-polysomnography; HRV: heart 
rate variability; LF = low frequency; HF = high frequency
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Apnea group were significant (p=0.041). We also observed 
a decrease in LF and an increase HF in both the Apnea 
and Severe Apnea groups, but these differences were not 
significant. The LF/HF ratio increased in all groups, but the 
changes were not significant. 
We did not observe sinus pauses ≥ 3 seconds, atrial 
fibrillation, flutter or any type of conduction defect or 
malignant ventricular arrhythmias (ventricular tachycardia 
or ventricular fibrillation). Patients in all groups, with few 
exceptions, presented with fewer than 10 ectopic beats 
per hour during monitoring. Forty-five (84.9%) patients 
exhibited at least one supraventricular ectopic beat while 
awake and 43 (81.1%) patients had one while asleep. Isolated 
ventricular ectopic beats or pairs were detected in 42 patients 
(79.2%) during wakefulness and in 37 patients (69.8%) 
during sleep. Patients in the Apnea and Severe Apnea groups 
presented with a decrease in the number of arrhythmias per 
hour during sleep as compared to wakefulness, except for 
the supraventricular ectopic beats observed in the Apnea 
group. These differences, however, were not significant. 
Supraventricular ectopic beats in the Control group 
predominated during sleep (Figure 3). No differences were 
observed among the groups with respect to the occurrence 
of ventricular or supraventricular arrhythmias.
DISCUSSION
In the present study, we were unable to demonstrate a 
relationship between OSA and the occurrence of ischemia, 
arrhythmias or heart rate variability in a select group 
of patients with coronary disease. These findings were 
unexpected, as hypoxemia in sleep apnea is associated with 
a risk of cardiac events, especially in patients with severe 
apnea. Gastaut et al.22 described a patient with Pickwickian 
syndrome and suggested that the majority of individuals 
suffering from this syndrome become drowsy during the day 
and sleep poorly at night because of a primary disturbance in 
wakefulness-sleep regulation due to their obesity. Since this 
report, many observations have been published regarding 
patients with sleep disturbances due to reduction or cessation 
of breathing for short periods.23 Today, OSA is considered to 
be a risk factor for cardiovascular events and sudden cardiac 
death.24,25 Its association with systemic high blood pressure 
has been suggested by a series of studies. Whether there is a 
relationship between nocturnal OSA and ischemia, however, 
remains controversial.26
Ambulatory electrocardiographic monitoring in patients 
with stable ischemic heart disease has demonstrated a 
circadian pattern of ischemia, finding that most ischemic 
episodes occur during the early morning hours.27 In the 
present study, the circadian pattern of ischemia did not 
change, which led us to conclude that OSA most likely did 
not influence the occurrence of ischemic episodes in our 
patients. The comparison between sleep and wakefulness 
showed a significant decrease in the number and duration 
of ischemic episodes during sleep in the three groups, as 
is commonly found in patients suffering from coronary 
disease without OSA. Although we cannot definitively 
explain this finding, we can assume that the ischemia was 
primarily associated with effort during daily activities and 
that hypoxia during sleep apnea was insufficiently severe to 
increase ischemic episodes. If this is the case, the most likely 
reasons why patients in the Severe Apnea group exhibited 
less ischemia during wakefulness compared to the Control 
group is because they commonly become drowsy during 
the day and have a higher body mass index. These may be 
limiting factors for physical exercise and most likely result 
in fewer effort-related ischemic episodes. Furthermore, the 
occurrence of ischemic episodes in the Apnea or Severe 
Apnea groups did not differ during sleep compared to the 
Control group. The incidence of coronary artery disease and 
ventricular impairment was similar in all groups and did not 
influence our results.
Previous studies have reported different conclusions 
from ours. Schäfer et al.28 analyzed 14 patients with OSA 
and coronary disease. They found that 85% of the ischemic 
episodes were concomitant with apneas and that nitrate 
administration failed to reduce the likelihood of ischemic 
episodes. These results differ from ours in many respects. 
The number of patients in their study was smaller, they 
employed conventional electrocardiograms instead of Holter 
monitoring and they defined an ischemic episode as when 
Figure 3 - Comparison of the number of ectopic ventricular and supraven-
tricular beats per hour during wakefulness and sleep in the same group
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the ST-segment deviation lasted 10 seconds or longer. This 
definition of ischemia is not consistent with the general 
consensus and it is possible that many ST-segment deviations 
thus did not reflect true ischemia. This may explain why 
nitrates failed to relieve the considered ischemic episodes. 
Peled et al.29 also studied 51 patients with OSA and coronary 
disease using inclusion criteria and methods similar to 
ours. They observed an exacerbation of ischemic events 
during sleep and amelioration with continuous positive 
airway pressure. Furthermore, the AHI did not differentiate 
between patients with and without nocturnal ischemia, a 
result similar to ours. Conversely, Mooe et al.30 reported an 
observational study that also used polysomnography and 
Holter monitoring in 132 patients who had been referred 
for coronary angiography on account of disabling angina. 
They observed a relationship between apnea/desaturation 
and ST-segment deviations when the ST-segment deviation 
occurred within 2 minutes after the breathing event. 
Nocturnal ischemic episodes occurred in 31% patients, but 
the association with apnea/desaturation was found in only 
19% of the patients, suggesting only a limited correlation 
between ischemic episodes and sleep-disordered breathing.30 
Although their methods and definition of ischemia were 
similar to ours, their patients were randomly selected from a 
group that had been referred for coronary angiography and 
that did not necessarily exhibit any symptoms of OSA. ST-
segment depressions during sleep were described in patients 
with OSA and without coronary disease.10
In the present study, heart rate variability was not 
studied during sleep since it is influenced by respiration, 
and the respiratory events of sleep apnea may compromise 
the primary objective of associating heart rate variability 
with autonomic changes in these patients. The comparative 
analysis of heart rate variability in the three groups did 
not reveal significant differences. In the Control group, 
changes in heart rate variability occurred as expected. We 
also observed an increase in LF and the LF/HF ratio in 
the post-polysomnography period, reflecting sympathetic 
predominance after awakening. In the Apnea and Severe 
Apnea groups, however, there were increases in certain 
parameters associated with vagal tone (i.e., RMSSD, 
PNN50 and HF), suggesting that these patients did not have 
a physiological sleep period and did not really “wake up”. 
Our results and those of others31-34 suggest that patients 
with severe sleep apnea may not exhibit marked differences 
between sleep and wakefulness and, as a result, a non-
homogeneous variability in heart rate will likely occur. The 
relationship between OSA and changes in autonomic activity 
is still controversial and deserves further investigation.
Arrhythmias were infrequent in our cohort. We did not 
observe any serious arrhythmias such as atrial fibrillation, 
bouts of ventricular tachycardia, severe bradyarrhythmias or 
conduction defects, and no differences were detected among 
the three groups in respect of the occurrence of ectopic beats. 
There was a non-significant decrease in ventricular and 
supraventricular ectopic beats during sleep when compared 
to wakefulness in all groups except for the Control group, 
where an increase in supraventricular ectopic beats was 
observed during sleep. Past studies have associated sleep 
respiratory disturbances with atrial fibrillation but only in 
patients with congestive heart failure or recent myocardial 
revascularization,35,36 which were exclusion criteria in our 
study. Recently, Olmetti et al.37 suggested that nocturnal 
bradyarrhythmias are associated with severe OSA. However, 
Clementy et al.38 concluded that although bradycardias may 
dominate in these patients, it is difficult to link arrhythmias 
to sleep apnea syndrome or to an associated disease in the 
absence of controlled studies. 
The controversies regarding the relationships between 
sleep apnea and myocardial ischemia, and between heart 
rate variability and arrhythmias can be explained in part 
by selection bias and also because OSA is a complex 
syndrome that involves hypoxemia, endothelial dysfunction, 
inflammation and sympathetic stimulation.7-9 
We conclude that in our selected group of patients with 
stable coronary disease, the severity of OSA was not directly 
associated with myocardial ischemia, heart rate variability 
or arrhythmias. Furthermore, OSA did not change the 
circadian pattern of ischemia. Our study was limited to a 
selected group of patients with stable coronary disease and 
without signs and symptoms of heart failure. Our results may 
therefore not be applicable to patients with severe angina or 
ventricular dysfunction. 
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